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Sickle cell disease (SCD) patients are at high risk of
contracting pneumococcal infection. To address
this risk, they receive pneumococcal vaccines, and
antibiotic prophylaxis and treatment. To assess the
impact of SCD and these interventions on pneumo-
coccal genetic architecture, we examined the
genomes of more than 300 pneumococcal isolates
from SCD patients over 20 years. Modern SCD
strains retained invasive capacity but shifted away
from the serotypes used in vaccines. These strains
had specific genetic changes related to antibiotic
resistance, capsule biosynthesis, metabolism, and
metal transport. A murine SCD model coupled with
Tn-seq mutagenesis identified 60 noncapsular pneu-
mococcal genes under differential selective pressure
in SCD, which correlated with aspects of SCD patho-
physiology. Further, virulence determinants in the
SCD context were distinct from the general popula-
tion, and protective capacity of potential antigens
was lost over time in SCD. This highlights the impor-
tance of understanding bacterial pathogenesis in the
context of high-risk individuals.
INTRODUCTION
Streptococcus pneumoniae (pneumococcus) is a major cause of
childhood illness worldwide, causing approximately 14 millionCell Hepisodes of invasive disease and 1 million deaths per year. The
first step in invasive pneumococcal disease (IPD) is nasopharyn-
geal (NP) colonization, but asymptomatic carriage is common,
especially in early childhood (30%–50%) (Daw et al., 1997).
Colonization is usually established by a single pneumococcal
strain and persists for 1–2 months before clearance (Ghaffar
et al., 1999). Pneumococci lack clustered regularly interspaced
short palindromic repeats (CRISPR) systems to protect genomic
content and are naturally highly transformable, permitting rapid
genetic response to evolutionary pressures (Bikard et al., 2012;
Croucher et al., 2011). For example, introduction of the 7-valent
pneumococcal conjugate vaccine (Prevnar; PCV7) in the USA in
2000 resulted in near-complete elimination of vaccine serotypes
and emergence of nonvaccine serotypes (NVT) in colonization
and IPD in the general population (Croucher et al., 2013a; Halasa
et al., 2013).
Sickle cell disease (SCD), a hemoglobinopathy characterized
by chronic hemolysis and sickled red blood cells, is the most
common genetic disorder worldwide, with 300,000 affected
infants born each year. Children with SCD have a 600-fold
increased risk of potentially fatal IPD compared with the general
population, despite similar colonization rates (Overturf, 1999).
The increased risk is related to hyposplenism, complement defi-
ciency, and chronic vascular inflammation promoting upregula-
tion of the ligand for pneumococcal invasion (Miller et al.,
2007; Rosch et al., 2010). To address this risk, children with
SCD receive long-term penicillin prophylaxis, frequent empiric
antibiotic treatment, and pneumococcal vaccines. Pneumo-
cocci colonizing children with SCD have been previously shown
to develop antibiotic resistance in response to the selective anti-
biotic pressure and demonstrate capsular serotype switching in
response to vaccines (Adamkiewicz et al., 2008; Steele et al.,ost & Microbe 15, 587–599, May 14, 2014 ª2014 Elsevier Inc. 587
Table 1. Demographic and NP Colonization Data
Patient Information 2004–2011
1994–1995
(Daw et al., 1997)
Evaluable patients 195 312
Median months on study (range) 48 (1–59) NA
Total number of nasopharyngeal
swabs
1,372 312
Pneumococcal colonization, n (%) 98 (7.1%)a 42 (13.5%)
Penicillin resistanceb
High level: nonmeningitis (PRP) 1 (1%) 3 (5.4%)c
Low level: meningitis (PNSP) 53 (54.1%) 29 (51.8%)c
Median age at enrollment, years
(range)
5.0 (0.1–17.7) 4.3 (0.3–5.4)
Median age at time of swab, years 6.9 4.3
Female gender 98 (50.3%) 141 (45.2%)
Black race 193 (99.0%) 312 (100%)
Sickle cell disease type
HbS/b-thalassemia 17 (8.7%) 24 (7.7%)
HbSS disease 178 (91.3%) 195 (62.5%)
Hydroxyurea use (ever during study) 106 (54.4%) NA
Penicillin prophylaxis (ever during
study)
134 (68.7%) 208 (67%)
Empiric antibiotic (ever during study) 195 (100%) NA
Vaccine coverage (ever during study)
Pneumovax: PPV23 (R1 dose) 186 (95.4%) NA
Prevnar 7: PCV7 (R1 dose) 193 (99.0%) 0 (0.0%)
Infection episodes; n (events/1,000
patient years)
Invasive pneumococcal disease 2 (2.8)d NA
Acute chest syndrome 95 (133) NA
Hospital admissions for infection 200 (280) NA
NA, not available.
aPneumococcal colonization rate in 2004–2011 adjusted to median age
of 4.3 years = 13.4%.
bIncludes data for an additional 12 isolates from the same cohort.
cClinical and Laboratory Standards Institute susceptibility breakpoints.
dPost-PCV7 rate in healthy children <5 years old = 0.26/1,000 patient
years; pre-PCV7 rate in SCD<5 years old = 24/1,000 patient years(Adam-
kiewicz et al., 2003; Hicks et al., 2007).
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paradigm for understanding how pathogens adapt to both clin-
ical interventions, including vaccination and antibiotic pressure,
as well as unique aspects of host pathophysiology underlying
heightened infection risk. Due to the combination of clinical
and host factors, we hypothesized that pneumococci found in
the SCD population would develop unique genomic adaptations
from the selective pressures imparted not only by clinical inter-
ventions but also the SCD host environment itself.
To characterize the pneumococcus emerging in the pediatric
SCD population between 2004 and 2011 and re-evaluate current
disease risk for these vulnerable children, we undertook the
largest longitudinal study of pneumococcal colonization in chil-
dren with SCD. We compared the results with a cohort from
1994–1995 to ascertain the impact of deployment of the conju-588 Cell Host & Microbe 15, 587–599, May 14, 2014 ª2014 Elsevier Igate PCV7 vaccine in 2000. We also acquired a broad range of
IPD isolates from healthy and SCD children from across the
United States and obtained sequence data for contemporary
NP isolates from the general population (GP) (Croucher et al.,
2013a). Whole-genome sequencing of 322 isolates, one of the
largest data sets assembled thus far, defined overall gene
content and identified genes with differential abundance
between isolates from SCD and the GP as well as between
historical and contemporary eras. A murine model of SCD
coupled to Tn-seq whole-genome mutagenesis and vaccination
experiments were used to identify and evaluate pneumococcal
gene networks under selective pressure in this host. These
data provide a comprehensive analysis of the influence of both
clinical interventions and the SCD host environment on the pneu-
mococcus, resulting in unique genetic selection and specialized
contribution of genes to virulence in these high-risk patients.
RESULTS
Modern Colonizing SCD Strains Retain Invasive
Characteristics and Evade Interventions
Pneumococcal strains were obtained from three sources: (1) 63
NP SCD isolates from 1994–1995 (Daw et al., 1997); (2) 186 IPD
SCD isolates from the CDC ABC bacterial surveillance core,
SJCRH patients, and published collections (McCavit et al.,
2011); and (3) 98 NPSCD isolates from a longitudinal study span-
ning 2004–2011 in 195 SCD children followed for up to 4 years
with serial NP swabs (Table 1). Children with SCD received
PPV23 vaccine after 2 years of age, penicillin prophylaxis from
birth to at least 5 years of age (Gaston et al., 1986), and frequent
empiric antibiotic therapy. PCV7 vaccine was given only in the
contemporary group. Multivariate analysis of the 2004–2011
NP data showed that younger age was significantly associated
with increased risk of colonization (OR = 0.783 per year of age
increase, p < 0.0001) and that, despite interventions, patients
had a colonization rate of 7.1%, a value unchanged from
1994–1995 after correction for age (the adjusted colonization
rate estimate for median age of 4.3 years was 13.4% in 2004–
2011 and 13.5% in 1994–1995). The rates of acute chest
syndrome and pneumonia remained high despite prophylactic
interventions (133 episodes/1,000 patient years).
Penicillin resistance in contemporary SCD NP isolates was
unchanged compared with the historical era for both low-level
(MIC > 0.06 mg/ml; 54% versus 51%; p = 0.87) and high-level
resistance (MIC > 2 mg/ml; 1% versus 5.4%; p = 0.14). Antibiotic
prophylaxis appears to have maintained pressure on pneumo-
cocci in the SCD population, leading to a sustained high rate of
penicillin resistance.
Capsular serogroup was compared between strains from pre
(n = 112) and post (n = 225) PCV7 vaccine (Figure 1). After intro-
duction of PCV7, there was the expected marked decrease in
prevalence of PCV7 serotypes for both SCDNP and IPD isolates,
similar to previous studies in both SCD and normal hosts (Adam-
kiewicz et al., 2008; Dagan and Klugman, 2008; Halasa et al.,
2013) and reflecting the national trend following PCV7 introduc-
tion of serotype (Croucher et al., 2013a; Wroe et al., 2012). Unex-
pectedly, there was also a marked shift away from the additional
serotypes in the not-yet-deployed PCV13 (Figure 1C; p <
0.0001). This indicates that the majority of serotypes found innc.
Figure 1. Serotype Replacement in Pneumococcal Isolates from Children with Sickle Cell Disease
Serotype distribution and vaccine serotype representation for NP (A and C; n = 113) and IPD isolates (B and D; n = 221) from SCD patients before and after
introduction of PCV7 pneumococcal vaccine in 2000. Different color bars in (A) and (B) represent distinct time periods for which strains were isolated. Different
color bars in (C) and (D) represent the different vaccine serotypes in relation to inclusion in conjugate vaccines: included in PCV7 (white bars), additional serotype
included in PCV13 (gray bars), or not included in either vaccine (black bars). Data were available for pre- (1994–2000) and post-PCV7 (2004–2011) time periods for
both IPD andNP isolates, and for the intervening period (2001–2003; during rollout of PCV7) for invasive isolates only, as NP isolates were not collected during this
period (***p < 0.001 by Fisher’s exact test).
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new PCV10 and PCV13 vaccines prior to their deployment.
The risk for IPD posed by the emerging nonvaccine serotypes
(NVT) is amajor unanswered question (Syk et al., 2014). Invasive-
ness depends in part on noncapsular genomic content which
could be derived from two general processes with potentially
distinctly different invasive potential: capsular switching to NVT
while maintaining an invasive, fully virulent genome or serotype
replacement via selection of previously rare NVT capsules and
potentially less-virulent genomes (Wyres et al., 2013). To
address this question, we performedwhole-genome sequencing
on 322 SCD strains and determined similarity of all SCD strains in
relation to the GP isolates. For the GP cohort, we also compared
data from a recently published cohort from pediatric patients in
the post-PCV era using the same sequencing technology
(Croucher et al., 2013a).Cell HTo ascertain the degree of shared protein coding content as
well as single nucleotide variants (SNVs) in the core genome
between the various isolates, we utilized three approaches: a
comparative analysis using either SNVs (see Figure S1A avail-
able online) or genome composition (Figure S1B), and a hybrid
approach leveraging both the SNV and gene content (Figure 2).
Such pangenome analysis has been previously shown to provide
greater strain resolution compared to methods based on SNV
analysis of core genes alone (Hall et al., 2010). An approach
using presence/absence of both core and accessory genes
has previously been shown to correlate reasonably well with
SNV approaches (Donati et al., 2010); hence we employed all
approaches to interrogate our strain database. Including the
gene content allowed for more accurate assignments than those
resolved by SNV alone based on average bootstrap values
across all nodes (0.55 for gene content, 0.58 for SNV, 0.65 forost & Microbe 15, 587–599, May 14, 2014 ª2014 Elsevier Inc. 589
Figure 2. Phylogeny of Pneumococcal Isolates Derived from Gene Content and Nucleotide Variants
(A) Relatedness of the historical SCD (blue text), contemporary SCD (red text), contemporary GP NP cohort (green text), and GenBank strains (black text) as
determined by SNVs in core genes and gene content. Colors of the branches reflect bootstrap values (red to green, representing 0.65–1.0). Outer circle reflects
strain serotype, serotypes included in PCV7 (green), PCV13 (blue), and nonvaccine strains (red) (asterisk represents highly supported clades chosen for further
analysis).
(B–E) Contemporary SCD IPD (dark red), historical SCD IPD (light red), contemporary SCD NP (dark blue), historical SCD NP (light blue), and GP NP (yellow). (B)
Numerous modern vaccine escape 19A SCD strains are closely related to the 19F historical CDC5 isolate. (C) Historical GP 19F invasive isolate has undergone
capsule switching to contemporary SCD 15A invasive isolates. (D) Contemporary SCD IPD and NP strains of several serotypes are highly related at the genetic
level. (E) An anomalous clade of NVT, nonencapsulated pneumococci with a high prevalence of macrolide resistance was identified in the SCD NP population.
Their basal position in the S. pneumoniae tree was determined using nonpneumococcus streptococcal species as outgroups.
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species like S. pneumoniae, low bootstrap values were typical
of deep internal clades, although more recently emerged clades
were often highly supported. The geographic distribution of the
samples was not a factor in the phylogeny or subsequent genetic
analyses, as comparison of the SCD NP isolates (Memphis) and
the SCD IPD isolates (nationwide) revealed not a single allele
found in significantly altered abundance between these
geographically distinct groups, similar to previous reports due
to wide circulation of pneumococcal strains (Donati et al.,
2010). Importantly, all analyses indicated the strains did not
segregate based on geography, time period, or disease state
(Figure 2A). Strains collected serially from individual patients
were also randomly distributed, indicating constant acquisition
of new isolates rather than persistent colonization. The effect
of recombination can only be incorporated into the individual
clades rather than the entire data set due to the diversity of our
sample, similar to previous reports (Croucher et al., 2013a).590 Cell Host & Microbe 15, 587–599, May 14, 2014 ª2014 Elsevier IHence, analysis was restricted to strains within the same clade
or within the hierarchal gene clustering approaches based on
gene content.
Genomic analysis revealed three important findings regarding
the status of pneumococci in the SCD population: First, a num-
ber of vaccine escape 19A variants were closely related to the
19F lineage (Figure 2B), and many NVT invasive variants (e.g.,
15A) were genetically similar to earlier VT invasive isolates
(e.g., 19F; Figure 2C), indicating a high incidence of capsule
switching. Contemporary NVT serotypes were found in both
NP and IPD classes (such as 35B, 6B, and 13 strains; Figure 2D),
indicating the NVT strains retained invasive capacity in SCD. Of
note is an anomalous clade of nontypeable pneumococci that
splits early in the tree, suggesting that a lineage arising soon after
S. pneumoniae diverged from S. mitis (Figure 2E). This clade
contains only NP isolates from different subjects across time
periods, and all isolates were acapsular both serologically and
by sequence homology. While penicillin resistance in this groupnc.
Figure 3. Contribution of Capsule Type and
Genetic Background to IPD
WT (black circles) and SCD (white circles) animals
challenged with the respective pneumococcal
strains indicate that regardless of capsule type or
genetic background, pneumococcal strains retain
high virulence potential in SCD. In WT animals the
clinical strains displayed varying degrees of viru-
lence dependent upon both capsule type and
genetic background, whereas all strains retained
equivalent virulence in SCD mice (*p < 0.05 by log
rank test).
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was much more frequent (80.0% versus 24.5%; p = 0.008)
with a higher median erythromycin MIC (>256 versus 0.19
mcg/ml; p = 0.002). No significant allelic differences were
observed between the NP and IPD SCD isolates, but the limited
sample size may not have sufficient power to identify all factors
contributing to invasiveness.
Since genomic analysis suggested that emerging NVT strains
retained invasive capacity in SCD, we sought to model the inva-
sive potential of these NVT isolates in a SCD murine system.
Using this model, the NVT strains showed varying degrees of
pathogenesis in WT mice, but all strains were highly virulent in
SCD mice (Figure 3). These data indicate that capsule type
may not be as critical a requirement for invasive disease in
SCD as the GP. Taken together, the data reveal that a high inva-
sive disease risk remains in SCD children outside the scope of
available conjugate vaccines. One important caveat is that
even though strains were chosen for mouse challenge based
on genetic similarity or capsule type, small alterations in geno-
type can confer strong alterations in virulence (Croucher et al.,
2013b). Since the animal model suggested that all isolates
retained high virulence in the SCDmodel independent of capsule
type or genetic background, we explored other factors that
might more accurately define infection risk in this patient
population.
SCD Isolates Show Altered Genomic Content over Time
To define any unique features in the SCD genome, contempo-
rary SCD isolates were compared to historical SCD and
contemporary GP isolates for total gene content. When genes
were identified via mapping of short reads to a reference strep-
tococcal gene set (95% homology cutoff, see Experimental Pro-
cedures), the contemporary SCD isolates appeared to have a
significantly smaller overall genome size by an average of 76
genes compared to the historical SCD or contemporary GP
strains (Figure 4A, p < 0.0001). In contrast, when genome length
(Figure 4B) and predicted ORFs (Figure 4C) were comparedCell Host & Microbe 15, 587–using a genome assembly approach,
this was not observed. The difference
observed in the contemporary SCD iso-
lates was maintained in comparison to
both the contemporary GP isolates as
well as the historical SCD isolates
regardless of sequence coverage (Fig-
ure 4D). Such an apparent decrease inhomologous genome content using a mapping approach while
preserving physical genome size could represent two pro-
cesses: actual loss of genetic content or gene chimerism arising
from increased rates of recombination. Actual loss of genes was
detected in approximately 50% of cases, while sequences of
the remainder of the apparently missing genes could be
matched to parts of more than one divergent pneumococcal
sequence, indicating novel mosaics arising from intragenic
recombination (Figure 4E). Interestingly, the number of loci
involved in recombination is very similar to that observed during
recombination events between S. mitis and S. pneumoniae un-
der penicillin pressure (Sauerbier et al., 2012). These events
were not the result of a single isolated incident, as overall the
changes were distributed throughout the chromosome, indi-
cating these events were occurring independently. The fact
that these events were preferentially observed in the SCD pop-
ulation indicates such strains may be outcompeted or rapidly
cleared in the GP.
We next sought to elucidate specific differences in genomic
content between contemporary SCD and GP isolates. This was
accomplished by pairwise comparisons of the frequency of the
individual alleles utilized for the gene content phylogenetic
reconstructions. At the single allele level, a large number of hypo-
thetical genes, transposable elements, and genes involved in
metabolic networks were differentially abundant or divergent
between these two groups (Figure 4F). As this approach is
homology based, these differences represent both complete
absence and divergent genes, such as the penicillin binding
proteins (PBPs) known for their mosaic sequence diversity.
Specifically, differences in four key groups were apparent:
PBPs, capsular biosynthesis genes, metabolic pathways, and
metal transport. Differences in genes for capsule biosynthesis
and PBPs are expected signatures in a population that routinely
receives prophylactic penicillin and has very high PCV7 vaccina-
tion rates (Croucher et al., 2011; Zapun et al., 2008). However,
the emergence of differences in metabolic networks and metal
uptake loci suggests that absence or recombination within599, May 14, 2014 ª2014 Elsevier Inc. 591
Figure 4. Genomic Comparisons of Similarity and Allelic Content
(A) Average number of genes per genome as determined by homology with known streptococcal genes. Number of genomes analyzed: GP (n = 24), SCD
historical (n = 141), SCD contemporary (n = 173), GP contemporary (n = 563), (*p < 0.0001 by Mann-Whitney U test).
(B and C) Genome length and predicted proteins based on the assemblies of the contemporary GP and SCD isolated showed no significant differences between
groups.
(D) Number of coding regions predicted by homology as a function of read counts indicates the contemporary SCD genomeswere significantly smaller compared
to SCD historical or contemporary GP isolates independent of sequence coverage.
(E) Putative intragenic recombinant genes that were called as absent by the read-mapping approach due to the disjoint mapping of reads to different members of
a single gene family (*p < 0.001 by Mann-Whitney U test). Error bars represent mean and SD.
(F) Breakdown of annotated function of alleles showing differential abundance or recombination between groups. Differing genes from the total of 3,316 genes for
each group: historical versus contemporary SCD NP (n = 188), historical versus contemporary SCD IPD (n = 188), contemporary SCD versus contemporary GP
(n = 338).
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neutral, whereas in the GP such disruptions may prove
detrimental.
Analysis of SCD Host-Selective Pressure by Tn-seq
Identification of genes associated with SCD or IPD via abun-
dance in the strain collection can be problematic, due to the
fact that very slight changes can impact virulence and the likely
multifactorial contribution of genes to bacterial fitness. Hence,
we opted for an experimental approach using Tn-Seq to model
selective pressures of SCD physiology on the contribution of
pneumococcal genes to bacterial fitness in this host (van Opij-
nen and Camilli, 2013). Pools of thousands of tagged, trans-
poson-induced loss-of-function pneumococcal mutants were592 Cell Host & Microbe 15, 587–599, May 14, 2014 ª2014 Elsevier Icreated in a GP invasive isolate (TIGR4) and injected into SCD
and WT mice. Bacterial mutants recovered from the blood of
septic mice were sequenced and compared to the input inoc-
ulum to generate a fitness value for each gene. If a gene
product contributes to pathogenesis, then its loss-of-function
mutant replicates less well in the host. Conversely, if deletion
of a gene is favorable, the mutant replicates more rapidly or es-
capes immune clearance and is overrepresented in the output
pool.
The fitness of each pneumococcal gene was calculated inde-
pendently for infection in either WT or SCD mice (Table S1).
Comparison of the data sets revealed 60 genes whose trans-
poson disruption resulted in significantly different fitness be-
tween the two hosts (Table S2), indicating distinct requirementsnc.
Figure 5. Host-Specific Differences in Contribution of Two Pneumococcal Genes to Virulence and Protection by Vaccination
(A–E) Iron transporter SP1032. (A) Equivalent CFUs of TIGR4 and the SP1032 deletion mutant were coinoculated into wild-type (WT) and SCD mice, and the
respective amounts of each strain recovered from blood at 24 hr were enumerated. A fitness value of 1 indicates that the mutant and TIGR4 parent have equal
virulence. Each data point represents an individual mouse, and medians are shown by lines (*p < 0.01 by Mann-Whitney U test). (B and C) Vaccination with
Sp1032/PiaA confers protection against subsequent challenge in WT but not SCD mice (*p < 0.05 by log rank test). (D and E) Alterations of the SP1032 gene in
SCD isolates shown by genomic sequencing (D) and PCR (E) reveal significant divergence/point mutations (red bars) and deletions/truncations (red lines).
(F–H) Complement degrading proteinase SP1449. (F) Attenuation of the SP1449mutant inWT but not SCDmice (experiment performed as indicated in A). (G and
H) Wild-type (G) and SCDmice (H) were vaccinated with recombinant CppA with alum or alum alone and subsequently challenged with TIGR4. Vaccinated wild-
type mice showed significantly improved survival (p = 0.03 by log rank test), but the vaccine conferred no protection for SCD mice.
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significantly lowered fitness selectively in WT relative to SCD
mice, while disruption of 19 other genes significantly lowered
fitness in SCD relative to WT mice (Figure S2). Moreover, the
population bottleneck from indiscriminant bacterial clearance
was significantly greater in WT animals compared to SCD (Fig-
ure S3). Thus the bloodstream of normal mice is not only a
more hostile environment for S. pneumoniae but also is a signif-
icantly distinct environment compared to SCD.
The differential fitness of the gene knockouts predicted by
Tn-seq was validated by creating individual deletion mutations
for six genes: five which had shown reduced fitness in WT but
not SCD hosts, and one with reduced fitness only in SCD.
Compared to the parental TIGR4 strain in a competitive index
model of pneumococcal bacteremia, the mutant fitness pre-
dicted by Tn-Seq proved robust (Figures 5A, 5D, and S4). These
data indicate that pneumococci utilize distinct virulence gene
networks in a host-specific manner. This also predicts that there
could be a unique and defined set of critical genes differentially
selected by SCD host pathophysiology.Cell HHuman SCDHost Physiology Correlateswith Tn-seq and
Genomic Content
To relate the putative SCD genes identified in the Tn-seq analysis
to the human context, two analyses were performed: the func-
tion of the pneumococcal gene product was compared to known
SCD pathophysiology, and the frequency of mutation of these
genes in clinical SCD isolates was determined, hypothesizing
that genes dispensable in the SCD host may not be maintained
or may be significantly divergent in the altered contemporary
SCD genome.
The functions of genes under selective pressure in SCD mice
correlated strongly with aspects of SCD pathophysiology in
humans, including abnormal iron homeostasis, purine meta-
bolism, and complement function (Table 2). Second, six genes
predicted by Tn-seq to be under SCD pressure were either a
distinct allelic variant, altered, or absent in contemporary clinical
SCD isolates. One important feature to note is that while Tn-seq
represents an IPD model of bacterial fitness, pneumococcal
prevalence in the clinical cohort is also related to transmissibility
and colonization potential. We opted for this model becauseost & Microbe 15, 587–599, May 14, 2014 ª2014 Elsevier Inc. 593
Table 2. Clinical Correlationwith SCDPathophysiology of SelectedGeneswith Significant Differential Fitness betweenWild-Type and
SCD Mice
Locus
Virulence
Attenuated in Name
Correlation with Sickle Cell Disease
Pathophysiology
SP0045 WT phosphoribosylformylglycinamidine
synthase (putative)
These genes are involved in the purine biosynthetic
pathway. Serum levels of purines, which are
essential for bacterial DNA and RNA synthesis,
are elevated in SCD, possibly due to chronic
hemolysis, inflammation or renal disease
(Cerqueira et al., 2011).
SP0046 WT amidophosphoribosyltransferase
SP0050 WT formyltransferase/IMP cyclohydrolase
SP0051 WT phosphoribosylamine-glycine ligase
SP1032 WT iron-compound ABC transporter These genes are involved in homeostasis of metal
ions, especially iron. Iron metabolism in SCD is
complex with increased serum hemin due to
hemolysis, but depressed free iron due to
increased renal losses (Koduri, 2003).
SP1638 WT iron-dependent transcriptional regulator
SP0963 SCD dihydroorotate dehydrogenase, electron
transfer subunit
These genes are involved in nucleotide and DNA
synthesis. Purines and pyrimidines are more
abundant in the SCD host (Cerqueira et al., 2011).SP1018 SCD thymidine kinase
SP0768 WT ribosomal RNA large subunit
methyltransferase N
These genes are involved in the RNA synthesis
and processing. Availability of nucleotide
precursors is generally increased in the SCD
host (Cerqueira et al., 2011).
SP1483 WT ATP-dependent RNA helicase,
DEAD/DEAH box family
SP2016 SCD nicotinate-nucleotide pyrophosphorylase This gene is involved in the process of NAD
biosynthesis by catalyzing the production of
nicotinic acid mononucleotide. NAD+ plays an
important role in bacterial DNA biosynthesis.
Erythrocyte total NAD and NAD/NADH ratio
are both increased in the SCD host (Zerez
et al., 1988).
SP0823 SCD amino acid ABC transporter,
permease protein
These genes are involved in arginine transport and
regulation. Arginine is a critical source of nitric oxide
for the host and a required nutrient for pneumococci.
Availability of arginine in SCD hosts is known to be
decreased compared with healthy controls due to
reduced plasma levels (Sullivan et al., 2010).
SP0893 WT putative transcriptional repressor
SP1203 WT putative transcriptional repressor
SP1665 WT ylmE protein These genes are involved in amino acid
transport. Serum concentrations of many
amino acids, including leucine, isoleucine,
and valine, are significantly lower in SCD,
due in part to elevated urinary excretion
(VanderJagt et al., 1997).
SP0751 WT branched-chain amino acid ABC
transporter protein
SP0668 SCD glucokinase This gene is involved in glucose metabolism and
regulation of other metabolic pathways. Glucose
metabolism and availability of other sugars
appears to be altered in SCD, with higher
insulin levels and higher mean HOMA-IR
scores, attributable to oxidative damage
(Alsultan et al., 2010).
SP1619 SCD PTS system, IIA component This gene is involved in fructose transport and
metabolism. Plasma fructose concentration is
markedly decreased in the SCD host (Osuagwu
and Mbeyi, 2007).
SP1121 SCD 1,4-alpha-glucan branching enzyme This gene is involved in conversion of glucose to
glycogen, the primary storage carbohydrate for
bacteria. Availability of sugars, including glucose
and fructose, is altered in the SCD host (Osuagwu
and Mbeyi, 2007; Alsultan et al., 2010).
(Continued on next page)
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Table 2. Continued
Locus
Virulence
Attenuated in Name
Correlation with Sickle Cell Disease
Pathophysiology
SP0715 SCD lactate oxidase This gene is involved in metabolism of lactate to
pyruvate. In the SCD host environment, systemic
lactate clearance is impaired, erythrocyte lactate
uptake is increased, and serum lactate
dehydrogenase levels are increased (Freund
et al., 1992; Pattillo and Gladden, 2005).
SP1157 WT voltage-gated chloride channel family protein Function of these gene products appears to
be dependent on chloride and sodium
concentrations. SCD hosts have frequent
episodic hyponatremia during acute illness,
related to renal salt wasting (Radel et al., 1976).
SP1318 WT v-type sodium ATP synthase, subunit G
SP1449 WT C3-degrading proteinase This gene is involved in bacterial evasion
of complement-mediated immune killing.
Complement function is severely impaired
in SCD (Battersby et al., 2010).
SP1916 WT PAP2 family protein This gene is involved in synthesis of triacylglycerol
and glycerophospholipid. Serum triglycerides are
frequently elevated in SCD, whereas total and
HDL cholesterol are decreased (Seixas et al.,
2010).
WT, virulence attenuated in wild-type mice compared with SCD mice; SCD, virulence attenuated in SCD mice compared to wild-type mice.
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SCD isolates, transmission is not well modeled in a murine
system, and fulminant sepsis is a classic presentation of pneu-
mococcal disease in SCD. Genes identified to be under selective
pressure in themurinemodel by Tn-seq and found in significantly
(p < 0.05 by Fisher’s exact test) altered abundance in the SCD
clinical isolates were SP511, SP0946, SP1032, SP1449,
SP1483, and SP1835. For Sp0511, SP0946, SP1032, SP1483,
and SP1835, alterations were the result of truncations at the
N or C terminus, recombination events, or outright deletions.
In contrast, alterations in SP1449 consisted of point mutations
only.
The most significant difference was observed in the SP1032
iron transporter gene, found to be dispensable in the SCD host
by Tn-seq and found in significantly reduced abundance or
recombined in the modern SCD population (p < 0.001). The
divergence of the SP1032 sequences ranged from large dele-
tions to SNPs (Figures 5B and 5C). Furthermore, additional
genes in this operon that did not meet the required fitness-differ-
ence threshold in the Tn-seq analysis were also found to be
absent or divergent in the modern SCD isolates, including the
SP1034 permease component of the ABC transporter and
SP1035 ATP binding protein (p < 0.001). One potential expla-
nation for this locus to be under particularly strong negative
selection could arise from both the lack of necessity for iron
acquisition in the iron-rich SCD host and the fact that this protein
complex is highly immunogenic (Whalan et al., 2005). Such fac-
tors could allow formore permissive recombination events at this
locus in the SCD population that would be disadvantageous in
the GP. These data indicate the potential for the selective pres-
sures observed in murine models of SCD to be reflected in the
population genetics of isolates circulating and causing invasive
disease in these patients.Cell HEfficacy of a Vaccine Antigen Differed between Hosts
An important implication of these analyses relates to vaccine
design. Gene products required for full virulence are attractive
vaccine candidates, but are usually identified primarily in other-
wise healthy individuals. The most obvious shortcoming of a
potential vaccine would be if the potential vaccine target was
not present in strains circulating among a target population, as
was observed with the SP1032 gene in SCD. This has also
been observed both in our study and in previous reports whereby
a number of genes encoding antigenic surface proteins are easily
lost and reacquired due to selective pressure driven by the host
immune response (Donati et al., 2010; Muzzi et al., 2008).
Further, our demonstration that even universally conserved
genes, essential for IPD in normal hosts, are not required in
SCD suggests that these antigens would be paradoxically ineffi-
cacious for immunizing children with SCD. We tested this
hypothesis using two genes which were required for WT but
not SCD infection: Sp1032 (PiaA), which was extremely diver-
gent in SCD isolates, and SP1449 (CppA), which was highly
conserved in all isolates but shown by Tn-Seq and deletion ana-
lyses to be superfluous in the SCD setting (Figure 5D). Following
vaccination with either recombinant CppA or PiaA, challenge
with TIGR4 showed strong vaccine-induced protection in WT
but not SCD mice (Figures 5E and 5F) despite similar antibody
titers (Figure S5). These data indicate that vaccines derived
from virulence determinants in normal hosts may not be effica-
cious in high-risk patient populations with a differing host
environment.
DISCUSSION
Identification of the underlying factors that contribute to height-
ened infection risk is a fundamental challenge in infectiousost & Microbe 15, 587–599, May 14, 2014 ª2014 Elsevier Inc. 595
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bility factor for dying of infectious disease is greater than any
other condition, including cardiovascular disease and cancer
(Sørensen et al., 1988). Heightened risk is associated with rare
defects in host immune defenses (Ram et al., 2010) or bacterial
adaptation to clinical interventions (Ding et al., 2009). The pneu-
mococcus is particularly adept at rapidly acquiring antibiotic
resistance and evading capsule-based vaccines (Adamkiewicz
et al., 2003; Halasa et al., 2013). Pneumococcal isolates from
children with SCD were previously known to be highly antibiotic
resistant as an adaptation to the high rate of antimicrobial expo-
sure in this population. It had been less clear whether the path-
ogen could tailor itself to an altered host metabolic environment,
resulting in strains capable of causing disease in high-risk indi-
viduals but not the GP. Using strains from one of the largest
longitudinal studies of pneumococcal colonization in children
with SCD coupled to extensive pneumococcal genomic
sequencing, the signatures of three distinct selective pressures
were clearly evident in the changes in the pneumococcal
genome over the last 20 years: penicillin prophylaxis, pneumo-
coccal vaccines, and the SCD host environment.
Medical interventions of penicillin prophylaxis and vaccination
are universally deployed in SCD children to decrease IPD. Over
20 years, there has been no change in overall pneumococcal
colonization rate in SCD children, and rates of IPD and pneu-
monia/acute chest syndrome remain markedly higher in SCD
than in the general population (Halasa et al., 2007; Payne et al.,
2013). Penicillin nonsusceptible pneumococcal colonization is
much more common in SCD children than in the GP (Daw
et al., 1997), but rates have not changed over time despite
PCV7 vaccination. Detection of nontypeable pneumococcal
isolates in this study, especially those with high-level macrolide
resistance, is particularly concerning, as nonencapsulated pneu-
mococci offer opportunities for accelerated gene transfer
between organisms due to their increased transformability. A
finding withmajor clinical impact is that contemporary SCD colo-
nizing strains have almost all been replaced with serotypes not
included in PCV13 (p < 0.0001), despite lack of exposure to
this new vaccine (only PCV7 had been deployed during the study
period). Emergent colonization with non-PCV7 serotypes, and
the erosion of PCV13 serotypes even before introduction of the
PCV13 vaccine, is particularly alarming in tandemwith the obser-
vation that SCD isolates retain virulence potential in SCD but not
necessarily the GP. This was reflected in murinemodels of infec-
tion whereby pneumococcal strains varied in lethality based on
capsular type or genetic background in WT but not SCD mice,
where they were all lethal. The invasive potential of strains
emerging by capsular serotype switching in response to vaccine
pressure has been recognized as a pressing question (Syk et al.,
2014). We conclude that circulating pneumococci are not only
excluded fromconjugate vaccine coverage by capsule switching
but also have retained invasive capacity in these vulnerable
hosts. This represents an unrecognized, persistent risk for
invasive infection in vaccinated SCD children who are uniquely
susceptible, even to strains that might rarely be pathogenic in
the GP.
One of the most challenging aspects of genomic analyses in a
naturally competent organism is the high rate of recombination.
Lateral gene transfer can obscure accurate phylogenetic recon-596 Cell Host & Microbe 15, 587–599, May 14, 2014 ª2014 Elsevier Istruction, as genes are transferred both within and outside of a
particular bacterial species. In the case of homologous recombi-
nation, different homologous positions in a SNV-based phyloge-
netic reconstruction can support different topologies. This will
result in low bootstrap support of phylogeny bipartitions. A
gene presence/absence approach can mitigate this problem
because it is not affected by the presence of SNVs that have
different evolutionary histories, although it is still prone to addi-
tive transfer events. The only assumption is that genes are
gained or lost along a phylogeny at a constant rate. Conse-
quently, we used a combined SNV-gene presence/absence
approach, since recombination between related streptococci
occurs frequently. We believe this approach ismore comprehen-
sive than using only SNV data when comparing strains
that frequently recombine with related species. Indeed, this
approach provides the best overall bootstrap support for the
phylogenetic reconstruction compared to either data set alone.
In addition to effects of penicillin and vaccine exposure,
whole-genome sequencing revealed a noticeable impact of the
SCD host environment on pneumococcal genome content.
One of the most striking features was the decreased homolo-
gous coding content of the contemporary SCD strains and the
extensive intragenic recombination leading to the creation of
chimeric genes from divergent sources. Potential explanations
for increased frequency of recombination in SCD isolates include
unique selection by the combination of a novel SCD host envi-
ronment, the global population bottleneck created by the intro-
duction of PCV7, and constant antimicrobial pressure. The
distinct population bottleneck effect imposed by penicillin pro-
phylaxis, vaccine coverage, and altered host physiology could
also result in a predominance of otherwise rare variants in this
population. Such a different bottleneck constraint agrees with
the breakthrough of infections in SCD mice by strains of signifi-
cantly low virulence forWTmice, a finding reflected in the clinical
isolates whereby atypical capsule types continue to cause inva-
sive disease in SCD. A lower Tn-seq bottleneck observed during
experimental SCD infection indicates that the SCD environment
is less hostile for pneumococcal survival and suggests that the
environment could result in variants that cause breakthrough
infection in SCD but not the GP. This was supported by the large
number of alleles showing differential abundance between the
contemporary SCD and GP isolates, a number similar to that
found between isolates before and after introduction of PCV
which completely reshaped the circulating pneumococcal
population.
Previous studies have showed high rates of antibiotic resis-
tance in pneumococci colonizing SCD hosts (Steele et al.,
1996). This occurred without decreased carriage rates, implying
that the organisms had developed unique features specific to
SCD penicillin prophylaxis. Our data expand and support this
notion in two important ways. For one, the increased proportion
of mosaic genes in the SCD but not GP isolates indicates that
distinct selective pressures have had a measurable effect
on the composition of the pneumococcal genome within the
individual patients. Second, strains that might otherwise be
noninvasive in the GP appear to retain full pathogenicity in
SCD, a prediction in line with our observations that all isolates
tested retained full virulence in SCD but not WT mice and that
strains with various targeted deletions predicted by Tn-seqnc.
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These findings indicate that rapid recombination events may
be more frequent in strains colonizing SCD patients, resulting
in strains with decreased fitness capacity when transmitted
back into the GP. The mechanism by which the sickle cell host
influences the pneumococcal genome remains unknown. It is
possible that individual mutations occur during periods of
carriage, that strains which are rapidly cleared in the GP may
colonize and cause IPD in SCD patients, or that transmission
to SCD patients from family members or other patients at clinic
visits occurs. A combination of these factors or other unrecog-
nized factors may also be responsible.
We identified 60 genes that had differential effects on bacterial
fitness in the SCD and WT host, and showed correlation of the
function of these genes with SCD pathophysiology. For
example, the SCD host has defects in complement function
(Test and Woolworth, 1994) and altered plasma levels of zinc,
iron, purines, amino acids, and carbohydrates (Darghouth
et al., 2011; Prasad et al., 1976), which in turn correlate with
the dispensability of complement degrading proteinase, a tran-
scriptional regulator of zinc/manganese influx, purine biosyn-
thesis enzymes, arginine utilization, and iron acquisition genes
in this population. These findings are underscored by the
genomic analyses of clinical SCD isolates that showed high
sequence divergence and even deletion of a subset of genes
that correlated with the lack of selective pressure to maintain
these functions. In the SCD host, the constraints of pathogen-
esis are clearly different, and hence genetic selection may pro-
ceed differently than in the GP. These studies establish that
host environments place recognizable, specific selective pres-
sures on bacterial evolution. This process in pneumococci is
rapid, likely facilitated by the plasticity of the genome, allowing
the possibility of emergence of a pneumococcus more tailored
to the SCD host than the GP.
We conclude that, although pneumococcal colonization rates
are similar in SCD and the general population, the environment of
the SCD host is more permissive to IPD, and, in contrast to the
GP, risk of infection appears to be driven less by capsule type
than by noncapsular genomic content. This pressure appears
to have created a unique evolutionary bottleneck that has
resulted in a shift of dozens of genes from essential to
nonessential for SCD virulence. The identification of strains lack-
ing important virulence determinants has important implications
for vaccine design. Gene products that are normally required for
disease progression in healthy hosts may not be required for
pathogenesis in highly susceptible individuals, and may even
be absent from strains causing disease. Both CppA (SP1449)
and PiaA (SP1032) are putative future vaccine candidate pro-
teins which appear to be dispensable for IPD in SCD disease.
Both vaccines protect wild-type but not SCD mice, and PiaA is
frequently absent or modified in pneumococcal strains colo-
nizing SCD patients. Inclusion of these antigens in vaccines
might be efficacious in the general population but provide inad-
equate protection in high-risk individuals with predisposing
medical conditions such as SCD. Extending Tn-seq and genome
sequencing to other disorders as a probe for differences in the
genes required for disease progression could aid in the develop-
ment of vaccines and therapeutics for high-risk patients. To
avoid excluding uniquely vulnerable groups, such as childrenCell Hwith SCD, from the benefits of new vaccines, these factors
should be considered in vaccine design.
EXPERIMENTAL PROCEDURES
2004–2011 Patient Cohort
All human studies were prospectively approved by the St. Jude Institutional
Review Board. Children (<18 years) with confirmed HbSS or HbS/b thalas-
semia disease attending the St. Jude MidSouth Sickle Cell Clinic were eligible
for enrollment. Enrollment was stratified by age (%24 months, >2–5 years, >5–
18 years). Visits were scheduled every 3months for children under 2 years, and
every 6 months for all patients 2 years and over. For up to 4 years from enroll-
ment, data collected at each routine visit included antibiotic use, vaccinations,
hydroxyurea treatment, surgical splenectomy, comorbidities, intercurrent
illnesses and hospitalization for infection, acute chest syndrome/pneumonia,
or serious bacterial infection (SBI). NP samples were collected at each visit
on sterile rayon swabs, plated directly onto blood agar, and cultured at 37C
for 48 hr in 5% CO2. S. pneumoniae isolates were identified by colony
morphology, Gram-stain, and catalase and optochin testing. Serogrouping
was performed by latex agglutination (Pneumotest-Latex, Statens Serum Insti-
tut, Denmark). Nontypeable or PCV7, PCV10, or PCV13 vaccine serogroup
isolates were serotyped by Quellung reaction.
Genome Sequencing and Analysis
All 322 SCD pneumococcal genomes were sequenced using the Hi-Seq with
100-base paired-end reads. Paired-end sequence data were acquired for a
sample of 327 GP strains from the European Nucleotide Archive (Croucher
et al., 2013a; accession number ERP000809). Reads were randomly selected
from each sample of theGPdata to give a similar range of genome coverage as
those of the SCD isolates. Adapters and low-quality terminal bases were
removed using Cutadapt (Martin, 2011) and the Fastx toolkit (http://
hannonlab.cshl.edu/fastx_toolkit/), respectively. Each sample had a minimum
of 106 reads (463 coverage for genome of 2.16 MB). Twenty-four complete
reference genomes were in silico sequenced using DWGsim (https://github.
com/nh13/DWGSIM) to reduce potential biases in the comparison of Illu-
mina-sequenced and fully assembled reference genomes. Three million
paired-end 100-base sequences were randomly sampled from the reference
genomes with linearly increasing error rates across each read from 0.001 to
0.01. All fully assembled genomes and plasmids from the genus Strepto-
coccus (n = 109) were downloaded as GenBank files and the coding
sequences were extracted using PERL. A total of 155,257 coding sequences
(hereafter referred to as genes) were reverse complemented when necessary,
translated, and used to construct a genome index for short-read alignment
using SHRiMP2 (David et al., 2011). OrthoMCL was used to partition the
reference set of genes into 8,668 orthologous groups ranging from 1 to 233
orthologs and in-paralogs across the reference genomes using an inflation
parameter of 3 (Li et al., 2003). All reads from both the Illumina-sequenced
and the in silico-sequenced genomes were aligned to the full set of strepto-
coccal reference genes by a paired-end, exhaustive mapping approach using
SHRiMP2 (David et al., 2011).
A gene was considered present in a sample using the mapping-based
approach if reads aligned toR95% of any member of an orthologous group.
Genes were also identified using the RAST server (Aziz et al., 2008) to annotate
genome assemblies. Genomes were assembled using Edena (Hernandez
et al., 2008) and PAGIT (Swain et al., 2012). The reference genome used for
contig scaffolding of each sample was determined by mapping sample reads
to each reference genome independently and selecting the one with the high-
est coverage. Further details regarding sequence analysis are detailed in the
Supplemental Information.
Tn-seq Calculation of Gene Fitness
Tn-seq was performed as described previously (van Opijnen et al., 2009; van
Opijnen and Camilli, 2010, 2012). After fitness was calculated for each inser-
tion, values were normalized against a set of neutral genes with no fitness
effect to express all fitness values relative to the wild-type background. Three
requirements were established to determine that a gene had a differential
effect on fitness in wild-type and SCD mice: (1) fitness was composed of atost & Microbe 15, 587–599, May 14, 2014 ª2014 Elsevier Inc. 597
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significantly different in a one-sample t test with p < 0.05 after Bonferroni
correction for multiple testing.
Statistical Analysis
Generalized estimating equation (GEE) model analysis was used to determine
independent risk factors for colonization and to adjust colonization rate for
age. GEE was used to account for possible correlation between repeated
measures from the same participants. Fisher’s exact test was used to deter-
mine significance of difference between proportions and the Mann-Whitney
U test was used to determine significance of difference between medians
for continuous variables.ACCESSION NUMBERS
The databank accession numbers for the sequence reads reported in this
paper are SAMN02737887–2738214.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and four tables and can be found with this article at http://dx.
doi.org/10.1016/j.chom.2014.04.005.
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